Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES) "ARIES"

Completed

Phase 3 Results N/A

Summary of Purpose

The purpose of this study is to compare the effect of 6 weeks of treatment with Rosuvastatin with 6 weeks of treatment with Atorvastatin in African American subjects with hypercholesterolemia.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 13 March 2009.

1 Mar 2002 26 Mar 2008 Unavailable 1 Mar 2004 1 Mar 2009 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Study Director: Russell Esterline AstraZeneca

    information.center@astrazeneca.com